Amedisys Stock News

BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul

B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.

BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul B.

B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.

TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021

TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021

Bank of America Corp DE reduced its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 13.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 345,377 shares of the health services providers stock after selling 54,172 shares during the quarter. Bank of []

Amedisys (NASDAQ:AMED) had its price objective decreased by Barclays from $236.00 to $213.00 in a research note released on Tuesday morning, Analyst Ratings Network reports. Barclays currently has an overweight rating on the health services providers stock. AMED has been the topic of several other reports. SVB Leerink raised their target price on Amedisys from [] The post Barclays Lowers Amedisys (NASDAQ:AMED) Price Target to $213.00 appeared first on ETF Daily News .

If you're looking for bargain stocks to buy that are down 30% or more in 2021, that's not an easy task. Here are 10 that fit the bill.

DekaBank Deutsche Girozentrale decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 80.0% in the 3rd quarter, Holdings Channel reports. The fund owned 3,782 shares of the health services providers stock after selling 15,091 shares during the quarter. DekaBank Deutsche Girozentrales holdings in Amedisys were worth $561,000 as of its most recent filing with []

TheStreet cut shares of Amedisys (NASDAQ:AMED) from a b- rating to a c rating in a report released on Friday, TheStreetRatingsTable reports. Several other analysts have also recently weighed in on AMED. Royal Bank of Canada cut their price target on shares of Amedisys from $244.00 to $221.00 and set an outperform rating on the […]

Kestra Private Wealth Services LLC bought a new position in Amedisys, Inc. (NASDAQ:AMED) during the 3rd quarter, Holdings Channel reports. The fund bought 6,505 shares of the health services providers stock, valued at approximately $970,000. Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Eubel Brady & []

Bell Bank lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 5.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,991 shares of the health services providers stock after purchasing an additional 329 shares during the quarter. Bell Banks holdings in Amedisys were []

WALTHAM, Mass.--(BUSINESS WIRE)--connectRN Inc., a tech-enabled platform built to improve clinicians lives through access to community, opportunity, and support, today announced it has completed a $76M financing, bringing its total raised to over $100M to date. Suvretta Capital Management and Avidity Partners co-led the round, along with HBM Healthcare Investments, Infinitum Asset Management, Adage Capital Management, Cormorant Asset Management and Park West Asset Management. Amedisys, a leade

Equities research analysts expect that Amedisys, Inc. (NASDAQ:AMED) will post $555.84 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Amedisys earnings, with the highest sales estimate coming in at $567.10 million and the lowest estimate coming in at $550.60 million. Amedisys posted sales of $550.71 million during []